1. Kusumoto FM, Schoenfeld MH, Wilkoff B, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm 2017; 14: e503-51.
2.
Bongiorni MG, Burri H, Deharo JC, et al. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. Europace 2018; 20: 1217.
3.
Bongiorni MG, Kennergren C, Butter C, et al. ELECTRa Investigators. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes. Eur Heart J 2017; 38: 2995-3005.
4.
Kołodzińska A, Kutarski A, Koperski Ł, et al. Differences in encapsulating lead tissue in patients who underwent transvenous lead removal. Europace 2012; 14: 994-1001.
5.
Nowosielecka D, Polewczyk A, Jacheć W, et al. Echocardiographic findings in patients with cardiac implantable electronic devices-analysis of factors predisposing to lead-associated changes. Clin Physiol Funct Imaging 2021; 41: 25-41.
6.
Polewczyk A, Nowosielecka D, Jacheć W, et al. Safety and efficacy of cardiovascular procedures monitored by transesophageal echocardiography. Echocardiography 2024; 41: e15884.
7.
Nowosielecka D, Polewczyk A, Jacheć W, et al. Transesophageal echocardiography for the monitoring of transvenous lead extraction. Kardiol Pol 2020; 78: 1206-14.
8.
Kosior J, Jacheć W, Polewczyk A, et al. To grade or not to grade safety requirements for transvenous lead extraction: experience with 2216 procedures. Kardiol Pol 2023; 81: 242-51.
9.
Thygesen K, Alpert JS, Jaffe AS, et al. Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). Circulation 2018; 138: e618-51.
10.
Harada Y, Koskinas KC, Ndrepepa G, et al. Postprocedural high-sensitivity troponin T and prognosis in patients with non-ST-segment elevation myocardial infarction treated with early percutaneous coronary intervention. Cardiovasc Revasc Med 2018; 19: 480-6.
11.
Pölzl L, Thielmann M, Sterzinger P, et al. Sex-specific troponin and creatine kinase thresholds after coronary bypass surgery. Ann Thorac Surg 2025; 119: 120-8.
12.
Machado MN, Rodrigues FB, Grigolo IH, et al. Early prognostic value of high-sensitivity troponin T after coronary artery bypass grafting. Thorac Cardiovasc Surg 2019; 67: 467-74.
13.
Stolte T, Lopez-Ayala P, Reichl J, et al. The impact of myocardial injury on outcomes in TAVI patients. Clin Res Cardiol 2024; 114: 385-94.
14.
Yano M, Egami Y, Abe M, et al. Impact of combining ablation index-guided and very high-power short-duration ablation at posterior wall adjacent to esophagus during perioperative period on procedural factors. J Cardiovasc Electrophysiol 2025; 36: 85-94.
15.
Belalcazar A, Heist EK. Comparison of efficiency of PFA catheter designs by computer modeling. J Cardiovasc Electrophysiol 2024; 35: 2382-93.
16.
Kosior J, Nowosielecka D, Jacheć W, et al. An increase in cardiac troponin T levels after transvenous lead extraction. Pol Heart J 2025; 83: 1392-9.
17.
Kutarski A, Jacheć W, Kosior J, et al. Discontinuation of cardiac implantable electronic device therapy after transvenous lead extraction. Kardiol Pol 2023; 81: 1113-21.
18.
Pietura R, Smyk T, Tułecki Ł, et al. Endovascular treatment of thoracic central vein pathology caused by pacemaker leads. Kardiol Pol 2018; 76: 1489.
19.
Blomström-Lundqvist C, Traykov V, Erba PA, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2020; 41: 2012-32.
20.
Bontempi L, Vassanelli F, Cerini M, et al. Predicting the difficulty of a transvenous lead extraction procedure: validation of the LED index. J Cardiovasc Electrophysiol 2017; 28: 811-8.
21.
Bontempi L, Curnis A, Della Bella P, et al. The MB score: a new risk stratification index to predict the need for advanced tools in lead extraction procedures. Europace 2020; 22: 613-21.
22.
Mazzone P, Tsiachris D, Marzi A, et al. Predictors of advanced lead extraction based on a systematic stepwise approach: results from a high-volume center. Pacing Clin Electrophysiol 2013; 36: 837-44.
23.
Jacheć W, Nowosielecka D, Ziaja B, et al. LECOM (Lead Extraction COMplexity): a new scoring system for predicting a difficult procedure. J Clin Med 2023; 12: 7568.
24.
Nowosielecka D, Jacheć W, Polewczyk A, et al. The role of transesophageal echocardiography in predicting technical problems and complications of transvenous lead extractions procedures. Clin Cardiol 2021; 44: 1233-42.
25.
Kutarski A, Pietura R, Młynarczyk K, et al. Pacemaker lead extraction and recapture of venous access: technical problems arising from extensive venous obstruction. Cardiol J 2012; 19: 513-7.
26.
Starck CT, Gonzalez E, Al-Razzo O, et al. Results of the Patient-Related Outcomes of Mechanical lead Extraction Techniques (PROMET) study: a multicentre retrospective study on advanced mechanical lead extraction techniques. Europace 2020; 22: 1103-10.
27.
Sood N, Martin DT, Lampert R, et al. Incidence and predictors of perioperative complications with transvenous lead extractions: real-world experience with National Cardiovascular Data Registry. Circ Arrhythm Electrophysiol 2018; 11: e004768.
28.
White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol 2011; 57: 2406-8.
29.
Sandoval Y, Jaffe AS. Type 2 myocardial infarction and myocardial injury: clinical practice considerations. J Am Coll Cardiol 2019; 73: 1846-60.
30.
Sherwood MW, Newby LK. High-sensitivity troponin assays: evidence, indications, and reasonable use. J Am Heart Assoc 2014; 3: e000403.
